Literature DB >> 18361265

Serum concentration of procoagulant, endothelial and oxidative stress markers in early primary varicose veins.

A Yasim1, M Kilinc, M Aral, H Oksuz, M Kabalci, E Eroglu, S Imrek.   

Abstract

OBJECTIVE: Endothelial disorders of the veins are considered to play a role in the pathogenesis of primary varicose veins and oxidative stress is implicated in these disorders. With this aim, we investigated vascular endothelial marker levels and the effect of endothelial damage on coagulation parameters and vasodilator substances to determine metabolic markers of oxidative stress in patients with varicose veins and vascular endothelial damage caused by oxidative stress.
METHODS: We investigated the levels of malondialdehyde (MDA), protein C, protein S, fibrinogen, von Willebrand factor (vWf), tissue plasminogen activator (tPA), vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), interleukin-12 (IL-12) and nitric oxide (NO) in the blood taken from the brachial vein of 25 patients with primary varicose veins (study group) and compared the results with 25 healthy volunteers (control group). We also investigated the urinary levels of prostaglandin I2 (PGI2) in the study group and compared the results with the control group.
RESULTS: There was no statistically significant difference between the study group and the control group with respect to the plasma levels of MDA, protein C, fibrinogen, tPA, IL-6, NO and urinary levels of PGI2. But plasma levels of protein S, vWf, VEGF and IL-12 were found to be statistically significantly higher in the study group than in the control group.
CONCLUSIONS: Although the systemically measured levels of protein S, vWf, VEGF and IL-12 were found to be higher in patients of primary varicose veins, levels of protein C, fibrinogen, homocysteine and PGI2 were not found to be statistically significant. No systemic increased oxidative stress seems to be related to the early stages of chronic venous insufficiency. Further studies are warranted for understanding the role of molecules such as NO, oxidative stress parameters and cytokines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18361265     DOI: 10.1258/phleb.2007.007014

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  6 in total

1.  Polymorphisms in inflammation-related genes and the risk of primary varicose veins in ethnic Russians.

Authors:  Alexandra Shadrina; Elena Voronina; Mariya Smetanina; Yakov Tsepilov; Kseniya Sevost'ianova; Andrey Shevela; Evgenii Seliverstov; Elena Zakharova; Evgeny Ilyukhin; Alexander Kirienko; Igor Zolotukhin; Maxim Filipenko
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

2.  Alterations in the Plasma and Red Blood Cell Properties in Patients with Varicose Vein: A Pilot Study.

Authors:  Lukasz Gwozdzinski; Anna Pieniazek; Joanna Bernasinska-Slomczewska; Pawel Hikisz; Krzysztof Gwozdzinski
Journal:  Cardiol Res Pract       Date:  2021-06-30       Impact factor: 1.866

Review 3.  TGF-β1 in Vascular Wall Pathology: Unraveling Chronic Venous Insufficiency Pathophysiology.

Authors:  Pedro Serralheiro; Andreia Soares; Carlos M Costa Almeida; Ignacio Verde
Journal:  Int J Mol Sci       Date:  2017-11-26       Impact factor: 5.923

4.  The effect of the ovarian varicose vein on the DNA methylation in the rat's oocyte.

Authors:  Amirhossein Mohammadi; Bagher Minaei Zangi; Mahshid Delfan Azari; Rafieh Alizadeh; Mohammad Salehi; Erfan Daneshi; Mohammad Jafar Rezaei; Mehdi Abbasi
Journal:  Iran J Basic Med Sci       Date:  2017-10       Impact factor: 2.699

Review 5.  Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases.

Authors:  Maurizio Forte; Valeria Conti; Antonio Damato; Mariateresa Ambrosio; Annibale A Puca; Sebastiano Sciarretta; Giacomo Frati; Carmine Vecchione; Albino Carrizzo
Journal:  Oxid Med Cell Longev       Date:  2016-08-29       Impact factor: 6.543

6.  Plasma concentration of selected biochemical markers of endothelial dysfunction in women with various severity of chronic venous insufficiency (CVI)-A pilot study.

Authors:  Magdalena Budzyń; Maria Iskra; Wojciech Turkiewicz; Zbigniew Krasiński; Bogna Gryszczyńska; Magdalena Paulina Kasprzak
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.